Table 2 CMR ventricular function in pulmonary hypertension and healthy control groups
From: Right ventricular myocardial deoxygenation in patients with pulmonary artery hypertension
| Variables | PAH (n = 42) | Healthy Controls (n = 11) | p-value |
|---|---|---|---|
| LVEF (%), median (range) | 70 (46–86) | 69 (51–75) | 0.875 |
| LV EDVI (ml/m2), median (range) | 70 (44–112) | 65 (45–81) | 0.302 |
| LV ESVI (ml/m2), median (range) | 21 (7–52) | 20 (13–28) | 0.645 |
| LV mass index (g/m2), median (range) | 51 (36–72) | 48 (39–68) | 0.280 |
| LV SV index (ml/m2), median (range) | 46 (32–71) | 45 (29–58) | 0.428 |
| RVEF (%), median (range) | 61 (45–79) | 63 (50–79) | 0.304 |
| RV EDVI (ml/m2), median (range) | 60 (30–111) | 60 (47–89) | 0.972 |
| RV ESVI (ml/m2), median (range) | 22 (12–61) | 22 (10–41) | 0.823 |
| RV SV Index (ml/m2), median (range) | 37 (15–60) | 38 (27–54) | 0.595 |
| RV ED Mass Index (g/m2), median (range) | 17 (9–42) | 13 (9–19) | 0.001 |
| RV (ED) mass/volume ratio, median (range) | 0.30 (0.22–0.49) | 0.22 (0.15–0.25) | < 0.001 |
| RV inferior wall thickness (mm), median (range) | 4 (3–9) | 3 (2–5) | 0.002 |